» Authors » Deepti Parashar

Deepti Parashar

Explore the profile of Deepti Parashar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 359
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Priya T, Patil P, Siva B, Roy D, Dhote R, Parashar D, et al.
Eur J Med Chem . 2025 Jan; 284():117227. PMID: 39752822
Investigations into fruit and vegetable processing residues (FVPRs) offer huge opportunities to discover novel therapeutics against many diseases. In this study, detailed investigation of Garcinia mangostana fruit peel extract led...
2.
Panda K, Alagarasu K, Tagore R, Paingankar M, Kumar S, Jeengar M, et al.
Viruses . 2024 Sep; 16(9). PMID: 39339965
RNA interference (RNAi) is a process in which small RNA molecules (such as small interfering RNAs or siRNAs) bind to specific messenger RNAs (mRNAs), leading to its degradation and inhibition...
3.
Roy D, Manumol M, Alagarasu K, Parashar D, Cherian S
Mol Biotechnol . 2024 Sep; PMID: 39264526
Dengue is one of the major mosquito-borne infectious diseases of the present century, reported to affect about 100-400 million people globally. The lack of effective therapeutic options has inspired several...
4.
Davuluri K, Shukla S, Kakade M, Cherian S, Alagarasu K, Parashar D
Front Cell Infect Microbiol . 2024 Jun; 14:1335189. PMID: 38895735
Background: Chikungunya virus (CHIKV), which causes chikungunya fever, is an arbovirus of public health concern with no approved antiviral therapies. A significant proportion of patients develop chronic arthritis after an...
5.
Shukla S, Kakade M, Cherian S, Alagarasu K, Parashar D
Phytomedicine . 2024 Mar; 128:155491. PMID: 38489894
Background: Dengue and chikungunya, caused by dengue virus (DENV) and chikungunya virus (CHIKV) respectively, are the most common arthropod-borne viral diseases worldwide, for which there are no FDA-approved antivirals or...
6.
Davuluri K, Ghanghav R, Ahire G, Kakade M, Cherian S, Alagarasu K, et al.
Virol J . 2024 Jan; 21(1):5. PMID: 38178163
Chikungunya virus (CHIKV) infection causes chikungunya, a viral disease that currently has no specific antiviral treatment. Several repurposed drug candidates have been investigated for the treatment of the disease. In...
7.
Alagarasu K, Patil J, Jadhav S, Chowdhury D, Bote M, Punekar M, et al.
J Med Virol . 2023 Nov; 95(11):e29253. PMID: 38009608
A surge in chikungunya was observed during 2020-21 in Pune district of Maharashtra, India. Whole genome sequencing and phylogenetic analysis of 21 samples/sequences revealed them as Indian ocean lineage of...
8.
Darole R, Bagad P, Gonnade R, Alagarasu K, Punekar M, Shukla S, et al.
Eur J Med Chem . 2023 Oct; 261:115849. PMID: 37804768
A series of Rhodamine type Anthrone-Spirolactam (ASL) derivatives Benzylimin-Anthrone-Spirolactam (ASL-1 to ASL-10) and Benzamide-Anthrone-Spirolactam (ASL-11 and ASL-12) were synthesized via a simple condensation reaction between Anthrone Spiro-lactamine (2) and various...
9.
Alagarasu K, Tomar S, Patil J, Bachal R, More R, Bote M, et al.
J Infect Public Health . 2023 Sep; 16(11):1830-1836. PMID: 37742447
Background: The burden of dengue infection needs to be monitored along with tracking of the changes in dengue virus (DENV) transmission intensity for vaccine introduction decisions. Methods: The seroprevalence of...
10.
Kasabe B, Ahire G, Patil P, Punekar M, Davuluri K, Kakade M, et al.
Front Cell Infect Microbiol . 2023 Jul; 13:1226054. PMID: 37424775
[This corrects the article DOI: 10.3389/fcimb.2023.1132538.].